Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07070362 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Digital Early Warning System for Acute Lung Injury in Liver Surgery

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Enrollment reduced 25% 4000 → 3000 participants
See other at-risk trials from Beijing Tsinghua Chang Gung Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment reduced: 4000 → 3000 participantsv2 Show 5 more changesShow less
    • Trial sites expanded: 1 → 4 locations
    • Trial arms changed: 1 → 2
    • Interventions: None-placebo (Other) to not stated
    • Collaborators expanded, about 20 words
    • Study description shortened, about 2 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to develop an explainable machine learning model that takes into account the characteristics of cardiopulmonary interactions. This model will enable early prediction of acute lung injury (ALI) in patients undergoing major liver surgery. The research will create a digital early-warning system for ALI, thereby supporting clinical diagnosis and treatment decisions. This, in turn, should help reduce the incidence and mortality rates associated with ALI.
Trial Details
NCT Number NCT07070362
Lead Sponsor Beijing Tsinghua Chang Gung Hospital
Collaborators: Huangdao District People's Hospital of Qingdao, Peking University International Hospital, The First Affiliated Hospital of Army Medical University (Southwest Hospital)
Conditions
(from sponsor)		 Acute Lung Injury(ALI), Liver Cirrhosis, ARDS, Human, MASLD, MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis), NAFLD (Nonalcoholic Fatty Liver Disease), Liver Cancer, Adult
Related terms Acute Lung Injury, Carcinoma, Hepatocellular, Liver Cirrhosis, Non-alcoholic Fatty Liver Disease, Respiratory Distress Syndrome
Enrollment 3,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov